Literature DB >> 20610126

Early onset methylmalonic aciduria and homocystinuria cblC type with demyelinating neuropathy.

Daniele Frattini1, Carlo Fusco, Valentina Ucchino, Barbara Tavazzi, Elvio Della Giustina.   

Abstract

Methylmalonic aciduria and homocystinuria, cblC type, is the most common inborn error of vitamin B(12) (cobalamin) metabolism. The recent cloning of the disease gene, MMACHC, has permitted genotype-phenotype correlation. In a 1-year-old girl, compound heterozygous c.271dupA and c.616C>T mutations in MMACHC were identified as causing an early onset methylmalonic aciduria and homocystinuria, cblC type, which was complicated by sensorimotor peripheral demyelinating neuropathy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610126     DOI: 10.1016/j.pediatrneurol.2010.04.007

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  13 in total

1.  Expanding the Spectrum of Methylmalonic Acid-Induced Pallidal Stroke: First Reported Case of Metabolic Globus Pallidus Stroke in Transcobalamin II Deficiency.

Authors:  Lance Harrington Rodan; Navin Mishra; Ivanna Yau; Andrea Andrade; Komudi Siriwardena; Ingrid Tein
Journal:  JIMD Rep       Date:  2013-02-21

Review 2.  Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.

Authors:  Nuria Carrillo-Carrasco; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

Review 3.  Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management.

Authors:  Nuria Carrillo-Carrasco; Randy J Chandler; Charles P Venditti
Journal:  J Inherit Metab Dis       Date:  2011-07-12       Impact factor: 4.982

4.  Epileptic syndrome with myoclonus as manifestation of adult-onset CblC deficiency.

Authors:  Roberta Di Giacomo; Ettore Salsano; Francesco Deleo; Chiara Pastori; Giuseppe Didato; Andrea Stabile; Rosalba Ferrario; Anna Rita Giovagnoli; Chiara Benzoni; Lidia Sarro; Elisa Visani; Laura Canafoglia
Journal:  J Neurol       Date:  2022-04-11       Impact factor: 6.682

5.  Peripheral nerve involvement in classic homocystinuria: an unusual association.

Authors:  Miguel Oliveira Santos; Ruth Geraldes; Isabel Conceição
Journal:  BMJ Case Rep       Date:  2016-09-28

6.  Spinal cord demyelination combined with hyperhomocysteinemia: a case report.

Authors:  Meimei Hao; Yan Zhang; Shuangxing Hou; Yanling Chen; Ming Shi; Gang Zhao; Yanchun Deng
Journal:  Neuropsychiatr Dis Treat       Date:  2014-11-03       Impact factor: 2.570

Review 7.  Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.

Authors:  Martina Huemer; Daria Diodato; Bernd Schwahn; Manuel Schiff; Anabela Bandeira; Jean-Francois Benoist; Alberto Burlina; Roberto Cerone; Maria L Couce; Angeles Garcia-Cazorla; Giancarlo la Marca; Elisabetta Pasquini; Laura Vilarinho; James D Weisfeld-Adams; Viktor Kožich; Henk Blom; Matthias R Baumgartner; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2016-11-30       Impact factor: 4.982

8.  Subacute onset leukodystrophy and visual-spatial disorders revealing phenylketonuria combined with homocysteinmia in adulthood: A case report.

Authors:  Chunchen Wang; Jieying Li
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

9.  Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort.

Authors:  Neeharika L Mathukumalli; Mridula R Kandadai; Jabeen A Shaik; Meena A Kanikannan; Rupam Borgohain
Journal:  Ann Indian Acad Neurol       Date:  2020 Jan-Feb       Impact factor: 1.383

10.  Adolescent/adult-onset homocysteine remethylation disorders characterized by gait disturbance with/without psychiatric symptoms and cognitive decline: a series of seven cases.

Authors:  Kai-Jie Chang; Zhe Zhao; Hong-Rui Shen; Qi Bing; Nan Li; Xuan Guo; Jing Hu
Journal:  Neurol Sci       Date:  2020-09-30       Impact factor: 3.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.